PANews, May 14 - According to CoinDesk, American billionaire investor Tim Draper stated in an interview that Bitcoin will replace the dollar as the world's primary reserve currency within the next decade. He reiterated his prediction that Bitcoin will reach $250,000 by the end of 2025 and pointed out that when Bitcoin can be used for everyday payments and tax payments, the dollar will lose its value. Draper cited the 2023 Silicon Valley Bank collapse as an example to emphasize the fragility of the traditional financial system and suggested that companies hold both fiat currency and Bitcoin to cope with banking crises. Additionally, Draper believes that while stablecoins help in the adoption of digital currencies, they will eventually face inflation issues just like fiat currencies. He specifically mentioned that the US Dollar Index has dropped 8% this year, hitting its lowest point since April 2022, which supports his prediction of the "decline of the dollar."
American Billionaire Investor Tim Draper: Bitcoin Will Replace the Dollar in 10 Years
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly

XRP Ledger adds account control feature, enabling enterprises to manage assets offline.

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.